PYYX
Pyxus International, Inc.3.1000
-0.1000-3.13%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
76.28MP/E (TTM)
-Basic EPS (TTM)
-0.12Dividend Yield
0%Recent Filings
8-K
10-Q
8-K
Shareholders back Pyxus board, plan
Pyxus International held its 2025 annual shareholder meeting on August 14, electing seven directors—John S. Alphin, Jamie J. Ashton, Patrick J. Bartels, Jr., Robert D. George, Cynthia P. Moehring, J. Pieter Sikkel, and Richard J.C. Topping—for one-year terms, with votes for ranging from 18.96 million to 19.18 million amid 67,017 to 271,277 withheld. Shareholders ratified Deloitte & Touche LLP as auditors for the fiscal year ending March 31, 2026, with 20.63 million in favor, approved executive compensation on an advisory basis (19.13 million for), and endorsed the Amended and Restated 2020 Incentive Plan (18.62 million for). Strong support signals board continuity. Yet broker non-votes hit 1.47 million across proposals.
8-K
Pyxus Q1 results align with expectations
Pyxus International reported first-quarter fiscal 2026 results on August 6, 2025, with sales of $508.8 million down from $634.9 million last year due to shipment timing, yet gross profit held at 12.9% amid higher pricing. Adjusted EBITDA fell to $29.5 million from $55.0 million, reflecting normalized buying cycles in Africa and South America that boost second-half visibility. Inventory rose to $1,089.8 million on larger crops. The company reiterates full-year guidance of $2.3–2.5 billion in sales and $205–235 million in adjusted EBITDA. Net debt climbed $90.3 million, but cash conversion improved to 160 days.
10-Q
Q1 FY2026 results
Pyxus International's Q1 FY2026 sales fell 19.9% year-over-year to $508.8M, driven by a 30.1% drop in kilo volumes from Africa and North America after accelerated shipments in the prior quarter, while gross profit dipped 21.8% to $65.6M with margins slipping to 12.9% from 13.2% on regional mix shifts. Operating income halved to $21.0M, but net loss widened to $15.8M or $(0.62) per diluted share from $4.6M profit, as interest expense eased 10.5% to $29.8M yet unconsolidated affiliates swung to a $1.3M loss; the EPS aligns with 25,670 diluted shares. Cash from financing via seasonal lines covered $495.3M operating outflow for larger Southern Hemisphere crops, lifting cash to $96.4M and inventories to $1,121.8M, with total debt at $1,336.0M and $324.6M availability under facilities like the expanded $150M ABL. Debt repurchases in prior months trimmed long-term obligations. Larger crop volumes signal supply balance ahead. Regulatory changes in tobacco sourcing pose ongoing risks.
BTI
British American Tobacco Indus
57.29-0.45
CHUC
Charlie's Holdings, Inc.
0.18+0.01
MO
Altria Group, Inc.
59.33+0.24
PM
Philip Morris International Inc
157.95-0.46
PNXP
Pineapple Express Cannabis Comp
0.01+0.00
RLX
RLX Technology Inc.
2.37-0.03
TOBAF
TAAT Global Alternatives Inc.
0.04+0.00
TPB
Turning Point Brands, Inc.
110.86+1.25
UVV
Universal Corporation
54.49-0.21
XXII
22nd Century Group, Inc
1.05+0.09